Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
MBBS, MD (Gastroenterology), Fellowship in ERCP
Internal Medicine Specialist
M.B.B.S., M.C.P.S. (Family Medicine), Postgraduate Diploma in Cardiology
Internal Medicine Specialist
M.B.B.S., M.C.P.S. (Family Medicine), Postgraduate Diploma in Cardiology
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Endocrinologist
M.B.B.S., F.C.P.S., MRCP-SCE Endorinology & Diabetes (UK), Fellow FCPS Endocrinology & Diabetes, MRCP Medicine (Glasgow), MCPS (Family Medicine), M-ESSM (Europe), MACE (USA), MGAED (Gulf)
Endocrinologist
M.B.B.S., F.C.P.S., MRCP-SCE Endorinology & Diabetes (UK), Fellow FCPS Endocrinology & Diabetes, MRCP Medicine (Glasgow), MCPS (Family Medicine), M-ESSM (Europe), MACE (USA), MGAED (Gulf)
Consultant Physician
M.B.B.S, M.C.P.S, M.D
Gastroenterologist
M.B.B.S., F.C.P.S (Gastroenterology), Advance Endoscopy Fellowship (USA)
Gastroenterologist
M.B.B.S., F.C.P.S (Gastroenterology), Advance Endoscopy Fellowship (USA)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures